1. Glioma targeted therapy: insight into future of molecular approaches
   Keyang Yang et al, 2022, Molecular Cancer CrossRef
2. Parkinsonian Patients Requiring Proteasome Inhibitors for Multiple Myeloma: Exceptional Circumstances Call for Extra Caution
   Pierre Rocanières et al, 2022, Journal of Parkinson's Disease CrossRef
3. The Future Glioblastoma Clinical Trials Landscape: Early Phase 0, Window of Opportunity, and Adaptive Phase I–III Studies
   Nicholas S. Cho et al, 2023, Current Oncology Reports CrossRef
4. Brain-Permeable Immunoproteasome-Targeting Macrocyclic Peptide Epoxyketones for Alzheimer’s Disease
   Ji Eun Park et al, 2024, Journal of Medicinal Chemistry CrossRef
5. Molecular targeted therapy: A new avenue in glioblastoma treatment (Review)
   Oula El Atat et al, 2022, Oncology Letters CrossRef
6. The NF-κB Pharmacopeia: Novel Strategies to Subdue an Intractable Target
   Daniela Verzella et al, 2022, Biomedicines CrossRef
7. The Proteasome Inhibitor Marizomib Evokes Endoplasmic Reticulum Stress and Promotes Apoptosis in Human Glioblastoma Cells
   Magdalena Kusaczuk et al, 2024, Pharmaceuticals CrossRef
8. Investigational new drugs against glioblastoma
   David Olayinka Kamson et al, 2021, Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies CrossRef
9. Drug Repurposing, a Fast-Track Approach to Develop Effective Treatments for Glioblastoma
   Ioannis Ntafoulis et al, 2022, Cancers CrossRef
10. An insight into the ubiquitin-proteasomal axis and related therapeutic approaches towards central nervous system malignancies
    Pritam Kumar Roy et al, 2022, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef